Catalyst Wire Dossier Catalyst Wire Dossier

PDE4 inhibitor

PDE4 inhibitor · GlaxoSmithKline
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for PDE4 inhibitor, covering 2017-06-20 to 2017-06-20. Get the full timeline:

Most recent: Clinical Trial Update: Healthy Volunteer Positron Emission Tomography (PET) Brain Occupancy Study of a Phosphodiesterase 4 (PDE4) Inhibitor in Huntington's Disease [Phase 1]

See pricing